Schizophrenia.com
OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder
News
everhopeful
July 1, 2021, 12:39pm
1
Related topics
Topic
Replies
Views
Activity
Zysis Receives US Patent for Long Acting Oral Aripiprazole Once Weekly
Medications
1
758
November 13, 2013
Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
News
0
239
January 6, 2019
New Liquid Version of Clozapine Available
News
3
3663
February 12, 2014
Letter from GWPharma
Medications
5
998
May 31, 2016
Quetiapine for schizophrenia: more transparency needed in clinical trial reporting
Medications
3
721
June 16, 2015